Ergocryptine, 2-bromo-, monomethanesulfonate (salt)

Base Information

• Chemical Name: Ergocryptine, 2-bromo-, monomethanesulfonate (salt)
• CAS No.: 22260-51-1
• Molecular Formula: C32H40BrN5O5^.CH4SO3
• Molecular Weight: 750.711
• Hs Code.: 29396900
• NSC Number: 755915
• Mol file: 22260-51-1.mol

Synonyms:Bromocryptine mesylate;C32-H4O-Br-N5-O5.C-H4-O3-S;Ergocryptine, 2-bromo-, monomethanesulfonate (salt);SPECTRUM1500151;HMS502C19;HMS1920I05;HMS2091O07;Pharmakon1600-01500151;Ergotaman-3', 6',18-triona, 2-bromo-12'-hidroxi-2'-(1-metiletil)-5-(2-metilpropil)-, (5alfa)-, Metanosulfonato ( 01:01);Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-, monomethanesulfonate (salt);CCG-40056;NSC755915;SR-05000001578;SR-05000001578-1

Chemical Property of Ergocryptine, 2-bromo-, monomethanesulfonate (salt)

Chemical Property:

• Appearance/Colour: white solid
• Vapor Pressure: 0mmHg at 25°C
• Melting Point: 192-196° (dec)
• Boiling Point: 891.3 °C at 760 mmHg
• PKA: 4.90(at 25℃)
• Flash Point: 492.8 °C
• PSA: 180.96000
• LogP: 3.98220
• Storage Temp.: 2-8°C
• Solubility.: H2O: 0.8 mg/mL
• Hydrogen Bond Donor Count: 4
• Hydrogen Bond Acceptor Count: 9
• Rotatable Bond Count: 5
• Exact Mass: 749.20940
• Heavy Atom Count: 48
• Complexity: 1320

Purity/Quality:

99% ^*data from raw suppliers

Bromocriptine mesylate ^*data from reagent suppliers

Safty Information:

• Pictogram(s): Xn
• Hazard Codes: Xn
• Statements: 20/21/22
• Safety Statements: 22-24/25-36

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O
• Isomeric SMILES: CC(C)CC1C(=O)N2CCC[C@H]2C3(N1C(=O)[C@](O3)(C(C)C)NC(=O)C4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O
• Description: Bromocriptine is a dopamine receptor agonist (Kis = 1,659, 12.2, 12.2, 59.7, and 1,691 nM for dopamine D1, D2, D3, D4, and D5 receptors, respectively). It also binds to the serotonin (5-HT) receptor subtypes 5-HT1A and 5-HT1D (Kis = 12.9 and 10.7 nM, respectively), as well as α1-adrenergic receptors (Kis = 1.12-4.17 nM). Bromocriptine (5 mg/kg) restores locomotor activity, without inducing dyskinesia, in a macaque model of Parkinson’s disease induced by MPTP. Formulations containing bromocriptine have been used in the treatment of Parkinson''s disease, hyperprolactinemia-associated dysfunctions, and acromegaly.
• Uses: Dopamine receptor agonist; derivative of the ergotoxin group of ergot alkaloids. Prolactin inhibitor; antiparkinsonian. 2-Bromo-α-Ergocryptine is a dopamine receptor agonist. 2-Bromo-α-Ergocryptine is a derivative of the ergotoxin group of ergot alkaloids. 2-Bromo-α-Ergocryptine is a prolactin inhibitor; antiparkinsoni an. 2-Bromo-α-ergocryptine methanesulfonate salt has been used:as D2 agonist in bird zebra finchesfor Prl secretion inhibitor in micefor the inhibition of motility in planaria worm
• Therapeutic Function: Prolactin inhibitor

Technology Process of Ergocryptine, 2-bromo-, monomethanesulfonate (salt)

There total 1 articles about Ergocryptine, 2-bromo-, monomethanesulfonate (salt) which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield:

methanesulfonic acid (75-75-2,98527-29-8) + Bromocriptine (25614-03-3) → Cycloset (22260-51-1)

Guidance literature:

In methanol; water; at 4 ℃; for 2.58333h; Solvent;

upstream raw materials:

methanesulfonic acid

Bromocriptine

Refernces